Mr Hide Yamamoto is a Consultant Urological Surgeon and Lead for Urological Cancer at Maidstone and Tunbridge Wells NHS Trust.  

He specialises in the diagnosis and treatment of prostate cancer and bothersome urinary symptoms caused by enlarged prostate (benign prostatic hyperplasia or BPH).  He offers a personalised approach to every patient tailored to their unique needs.

For men with possible prostate cancer he would focus on achieving a safe, fast and accurate diagnosis through the use of multiparametric MRI and MRI-guided transperineal biopsies.

For men needing cancer treatment he carries out nerve-sparing robotic prostate cancer surgery (DaVinci) with functional outcomes aligning with best published results.

He also specialises in the management of BPH including laser BPH surgery (HoLEP) with very low complication rates.

Mr Yamamoto gained his primary medical qualification at Cambridge University.  Subsequently he went on to gain his PhD in prostate cancer with UCL supported by a British Urological Foundation Scholarship.

He is a pioneer of transperineal prostate biopsies performed under local anaesthetic and was one of the first in the UK to adopt the new approach. He has personally performed more than 1000 transperineal prostate biopsies and trains other urologists at national courses.

He is active in prostate cancer research as a Principal Investigator for the TRANSLATE study which investigates the best method for diagnosing prostate cancer.  He is on the Editorial Board for BJU International.

Mr Yamamoto sees his private patients at various hospitals in Kent, including Nuffield Tunbridge Wells, Spire Tunbridge Wells, and GenesisCare Maidstone.

‘My ethos is to offer early & accurate assessment for every patient and achieve the best possible outcome.  This may involve timely treatment but in many cases reassurance is all that is required.  I also consider patients’ experience of their care to be as important as their outcome.’